Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Meibomian Gland Dysfunction: full-pipeline trial registry
A small indexed set (9 trials) with no open enrollment listed right now.
Corpus placement: #1,916 of 28,707 conditions by registered trial count.
9 US clinical trials · none currently recruiting · #1,916 of 28,707 conditions by registered trial count
Meibomian Gland Dysfunction: 9 US clinical trials tracked, none currently recruiting.
Meibomian Gland Dysfunction is the subject of 9 registered US clinical trials on ClinicalTrials.gov, none currently recruiting. 1 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Tear Film Innovations, running 2 of these trials.
Enrollment posture brief
Registry condition meibomian-gland-dysfunction
OPEN 0 | RECR 0% | LATE 1 | EARLY 1 | RANK #1916 | SPON 2
Volume-matched condition peers
Nearest open-share peer: Accelerated Phase Chronic Myelogenous Leukemia (0% recruiting · 12 trials)
Meibomian Gland Dysfunction has no open enrollment in this registry pull (9 archived studies). Peers show how other volume-matched labels compare on open share. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Meibomian Gland Dysfunction on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Meibomian Gland Dysfunction is recruiting below its size-band peers.
0 of 9 indexed trials (0%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Meibomian Gland Dysfunction research.
Tear Film Innovations accounts for 2 of 9 trials (22.2%). 8 distinct sponsors appear on at least one study for this condition label.
-
Most Meibomian Gland Dysfunction trials plan to enrol fewer than 100 people.
Median target enrolment is 68 among the 9 trials that report a genuine target (sentinel values excluded). 6 of those (66.7%) plan for fewer than 100 participants.
-
Meibomian Gland Dysfunction research is mostly interventional.
9 interventional and 0 observational studies make up this index (100% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Indexed trials (enrollment closed)
9 total, page 1 of 1
Clinical Study Evaluating Nordlys™ SWT IPL for Dry Eye Disease (DED) Due to MGD
Candela Corporation
NCT06064071
Meibomian Gland Dysfunction Management
University of the Incarnate Word
NCT03652337
Effect of an Exploratory Vehicle on Meibomian Gland Dysfunction in Patients With Demodex
Tarsus Pharmaceuticals
NCT06054217
Comparison Between iLux and LipiFlow in the Treatment of Meibomian Gland Dysfunction (MGD): A 12-month, Multicenter Study
Alcon Research
NCT03956225
Comparison Between iLux™ and LipiFlow® in the Treatment of Meibomian Gland Dysfunction
Tear Film Innovations
NCT03055832
The Efficacy of an Ocular Emulsion in Meibomian Gland Dysfunction
Southern California College of Optometry at Marshall B. Ketchum University
NCT01207752
Thermal Pulsation Versus Warm Compress Treatment for Meibomian Gland Dysfunction
Jacksoneye
NCT06326931
Clinical Study Using Eye Lipid Mobilizer (ELM) With Heat and Vibration To Treat Evaporative Dry Eye Disease
Eyedetec Medical
NCT06242860
Tear Film Innovations iLux Safety Study
Tear Film Innovations
NCT03055897
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 1 |
| Phase 4 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Meibomian Gland Dysfunction records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Meibomian Gland Dysfunction trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Meibomian Gland Dysfunction page
9 registered trials, 0 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- No Meibomian Gland Dysfunction trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Tear Film Innovations sponsors the most Meibomian Gland Dysfunction trials on record, review their full trial history before evaluating a specific study. See Tear Film Innovations's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Meibomian Gland Dysfunction condition card totals 9 registered trials; most-linked intervention iLux 2020 System; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.